Unraveling combination therapies in lung cancer: oncogenic drivers, ICI resistance, and predictive biomarkers

“To predict resistance...there is a need for robust and novel predictive biomarkers, and combining different biomarkers simultaneously will become essential.”

Please enter your email to access content Read now